New Study Finds Aspirin Treatment Ineffective for Chronic Rhinosinusitis with Nasal Polyps
A recent clinical trial reveals that aspirin therapy offers no significant benefit for patients with chronic rhinosinusitis with nasal polyps, especially those hypersensitive to NSAIDs, emphasizing the need for alternative treatment approaches.
Recent research from the University of Eastern Finland, in collaboration with the University of Helsinki and HUS Inflammation Center, has revealed that aspirin therapy does not significantly improve symptoms or quality of life for patients suffering from chronic rhinosinusitis with nasal polyps (CRSwNP), particularly in those hypersensitive to non-steroidal anti-inflammatory drugs (NSAIDs). The study was published in the journal Allergy and involves a comprehensive clinical trial involving 26 patients with NSAID-exacerbated respiratory disease (N-ERD), asthma, and severe CRSwNP.
The trial involved administering aspirin desensitization to these patients, then randomly assigning them to receive either daily aspirin or a placebo over an 11-month period. The results showed no notable difference in symptom severity, lung function, or the number of corticosteroid courses needed during flare-ups between the two groups. While some indications suggested that aspirin therapy might slightly reduce nasal polyps and improve nasal symptom-related quality of life, these effects were not statistically significant.
Furthermore, adverse effects were common, occurring in 56% of patients taking aspirin and 30% of those on placebo. Side effects ranged from worsening respiratory symptoms, increased bleeding tendencies, to abdominal discomfort. About 18% of patients in the aspirin group discontinued treatment due to side effects. The study concludes that aspirin therapy, despite being affordable, does not offer a reliable benefit for most patients with CRSwNP and hypersensitivity to NSAIDs, and identifying individuals who might benefit remains challenging.
This research highlights the importance of evidence-based treatments and suggests that current biologic medications, although effective, are often expensive. The findings aim to guide clinicians in making informed decisions about managing CRSwNP associated with NSAID hypersensitivity.
Source: https://medicalxpress.com/news/2025-09-aspirin-therapy-ineffective-chronic-rhinosinusitis.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Understanding Breast Cell Changes During Motherhood and Their Impact on Breastfeeding Difficulties
New genetic insights into breast cell transformations during motherhood reveal potential causes of breastfeeding challenges and postpartum breast cancer, paving the way for innovative health strategies.
Are Long-Term Health Risks Associated with Fecal Transplants?
Recent studies highlight potential long-term health risks of fecal microbiota transplantation, emphasizing the need for safer microbiome therapies and personalized approaches to gut health treatments.
Innovative Multilingual AI Chatbot Enhances Emergency Department Triage for Bilingual Patients
Researchers at UNSW are developing a multilingual AI chatbot to improve emergency department triage accuracy for bilingual patients, addressing language and cultural barriers in urgent healthcare settings.
Child Hospitalized as Bird Flu Cases Rise in Cambodia
A child in Cambodia is hospitalized amid a surge in H5N1 bird flu cases, highlighting ongoing risks of avian influenza transmission and the importance of vigilant disease surveillance.